Your browser doesn't support javascript.
loading
Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55.
Gifford, Geoffrey; Vu, Vivian P; Banda, Nirmal K; Holers, V Michael; Wang, Guankui; Groman, Ernest V; Backos, Donald; Scheinman, Robert; Moghimi, S Moein; Simberg, Dmitri.
Afiliación
  • Gifford G; Translational Bio-Nanosciences Laboratory, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschu
  • Vu VP; Translational Bio-Nanosciences Laboratory, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschu
  • Banda NK; Division of Rheumatology, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, 1775 Aurora Court, Aurora, CO 80045, USA.
  • Holers VM; Division of Rheumatology, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, 1775 Aurora Court, Aurora, CO 80045, USA.
  • Wang G; Translational Bio-Nanosciences Laboratory, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschu
  • Groman EV; Translational Bio-Nanosciences Laboratory, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschu
  • Backos D; Computational Chemistry and Biology Core Facility, The Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, 12850 E. Montview Blvd., Aurora, CO 80045, USA.
  • Scheinman R; Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Colorado Center for Nanomedicine and Nanosafety, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Moghimi SM; Translational Bio-Nanosciences Laboratory, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; School of Pharmacy, Newcastle University, Newcastle upon Tyne NE1 7RU, UK; Institute of Cellular Medicine, Newcastle University
  • Simberg D; Translational Bio-Nanosciences Laboratory, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschu
J Control Release ; 302: 181-189, 2019 05 28.
Article en En | MEDLINE | ID: mdl-30974134

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Activación de Complemento / Antígenos CD55 / Leucocitos Tipo de estudio: Prognostic_studies Límite: Adult / Animals / Humans / Middle aged Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Activación de Complemento / Antígenos CD55 / Leucocitos Tipo de estudio: Prognostic_studies Límite: Adult / Animals / Humans / Middle aged Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos